Navigation Links
BioMarin to Present at the Cowen Health Care Conference
Date:3/1/2011

NOVATO, Calif., March 1, 2011 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Cowen Health Care Conference in Boston on Tuesday, March 8, 2011 at 8:00 a.m. ET.  

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com.  A replay of the call will be archived on the site for one week following the call.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase III clinical development for the treatment of MPS IVA, PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU, BMN-701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II clinical d
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. BioMarin Announces FDA Approval for Kuvan
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
8. BioMarin to Present at the Oppenheimer Healthcare Conference
9. BioMarin Announces Third Quarter 2009 Financial Results
10. BioMarin to Acquire LEAD Therapeutics
11. BioMarin to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Care®, Inc. (NASDAQ: TNDM ), a medical device ... its financial results for the quarter ended June 30, 2014. ... to the same period of 2013: , Sales grew ... t:slim Pump shipments grew 64 percent to 2,235 pumps from ... 30, 2014 to the same period of 2013: , ...
(Date:7/31/2014)... 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... its pipeline and new product development efforts. In the ... a Phase 2a study of AZ-002 (Staccato ® ... management of patients with acute repetitive seizures.  Additionally, ... product candidates for development - AZ-008 and AZ-009 ...
(Date:7/31/2014)... Mass. , July 31, 2014  Decision Resources ... technology market intelligence product Marketrack to now include ChinaTrack; ... device landscape in an interactive dashboard providing detailed ... procedure volumes at a hospital level. Other ... , Updated data feed: In addition to end-user surveys ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
... NEW BRUNSWICK, N.J., May 26, 2011 Johnson & ... strategies for its Pharmaceuticals business at a meeting with ... executive committee and pharmaceuticals segment will review how the ... unmet medical needs and outpace pharmaceutical market growth with ...
... 26, 2011 Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN ... States District Court for the Southern District of California issued ... (NYSE: LLY ) ("Lilly") relating to its litigation ... The U.S. District Court restrained Lilly from proceeding ...
Cached Medicine Technology:Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 2Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 3Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 4Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches 5Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly 2Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly 3Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly 4
(Date:7/31/2014)... If you have asthma, you may have an asthma ... recognize and respond to changes and understand when symptoms are ... green zone, you,re doing well, yellow means your asthma has ... urgent care. New guidelines are now available to help your ... green and away from the red zone. , "Management of ...
(Date:7/31/2014)... July 31, 2014 Developer Jamestown, L.P., ... on its Ponce City Market project in Atlanta’s Old ... Roebuck & Company building into best-in-class office, housing, and ... reviewed Jamestown’s experience with their construction webcam service to ... Jamestown wanted a construction camera for monitoring ...
(Date:7/31/2014)... Hoping to attract new customers who are looking for a ... ready to ship out free samples of product. A form ... offer fast and easy: http://www.nutrigold.com/Free-Samples , According to ... know that every time customers purchase one of our products, ... own health or the health of a loved one and ...
(Date:7/31/2014)... Ce-Classes.com has announced that they are ... professionals, a Systematic Review of Sexual Satisfaction . ... the International Journal of Clinical and Health Psychology. , ... a need to have accurate information about sexual satisfaction ... possible. The material provides a systematic review of ...
(Date:7/31/2014)... 2014 Dr. Stewart Shofner of ... first surgeons in the United States to successfully treat glaucoma ... smallest medical device ever approved by the FDA. Dr. ... the benefits of using a procedure known as Selective Laser ... and his colleagues now recognize that this procedure is a ...
Breaking Medicine News(10 mins):Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:NutriGold Launches Product Samples Page for its Supplements 2Health News:NutriGold Launches Product Samples Page for its Supplements 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 2Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 3Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 4
... Mass. (February 10, 2008) Unlike the rest of the ... That quirk dates back to the time when mammals began ... have red cells that contain nuclei that are inactive. Losing ... oxygen-carrying hemoglobin, thus enabling more oxygen to be transported in ...
... pose deadly burden , , SUNDAY, Feb. 10 (HealthDay News) ... doctors have long been familiar with this curious but ... there,s a greater likelihood that the surviving spouse will ... better understanding of the forces at work, realizing problems ...
... in the Government ... AIDS System, NEW ... its strong support for a Global,Fund to Fight AIDS, Tuberculosis and Malaria ... (WB) concerning,the second phase of National AIDS Control Programme (NACO) projects,implemented throughout ...
... Day - What better Valentine,s Day gift than the,"gift ... Saturn,retailers nationwide have held more than 1,900 community donor ... local blood center partners,as part of Saturn National Donor ... the launch will be hosted by,Cavender,s Saturn of San ...
... Antidepressant medications,which increase serotonin neurotransmitter levels can ... depression, impulsivity and,suicide risk in depressed patients, ... serotonin enhancement medications to dopamine,deficient patients, patients ... Dr. Rick Sponaugle, Medical Director of Florida ...
... ev3 Inc. (Nasdaq:,EVVV), a global endovascular device company, today ... as Chief Scientist and,from the company,s board of directors ... years, few people have shaped the treatment of,cardiovascular disease ... and vision for improving the lives of patients worldwide," ...
Cached Medicine News:Health News:How red blood cells nuke their nuclei 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 3Health News:AIDS Healthcare Foundation Shares World Bank, Global Fund Concerns Over Alleged Corruption at India's NACO 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 3Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 2Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 3
Cushing Little Joker periosteal elevators, solid handle, blade width 1/4" (6 mm), length 7 1/2" (191 mm)....
Molt 9 periosteal elevators....
Alexander periosteal elevators....
Lambotte periosteal elevators....
Medicine Products: